In contrast to the Sham group, BPH group showed an overexpression of Bcl-2 and Bcl-xL proteins, whereas COFE exerted dose-dependent inhibitory effects on the protein expression of Bcl-2 and Bcl-xL (Figure 3C). Here, BCL2 is linked to benign prostatic hyperplasia.